NCT00131287View on ClinicalTrials.gov

The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

December 31, 2006

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

Extract of Agaricus blazei Murill

Trial Locations (1)

886

Chung-Hua Hsu, Taipei

Sponsors

Lead Sponsor

ECbiotech Taiwan
All Listed Sponsors
lead

ECbiotech Taiwan

OTHER

NCT00131287 - The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM) | Biotech Hunter | Biotech Hunter